Skip to content

Q2 Holdings QTWO Options forfeited/expired (in dollars per share)

Options forfeited/expired (in dollars per share) at other companies

LivaNova logo
LivaNovaLIVN
$79.49+3.6%
TRV
Trevi Therapeutics, Inc.TRVI
$0.00
TFS Financial logo
TFS FinancialTFSL
$14.87-0.2%
Q2 Holdings logo
Q2 HoldingsQTWO
$0.00
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$167.80+12.6%
Baxter International logo
Baxter InternationalBAX
$54.86-15.9%

Other financials

Income statement

See full
Revenue$216.5M+14.1%
Gross profit$127.9M+26.7%
Operating income$27.7M+1,165%
Net income$26.6M+460%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$218.3M-34.3%
Total debt$343.9M+45.3%
Total equity$611.7M+12.1%
Total assets$1.2B-7.7%

Cash flow

See full
Operating cash flow$56.3M+29.4%
CapEx$6.6M+740%
Free cash flow$49.7M+16.3%

Valuation

See full
Market cap$2.71B-39.3%
Enterprise value$2.83B-35.4%
P/E36.7×
P/S3.3×-2.9×

Profitability

See full
Gross margin55.6%+3.8pp
Operating margin8%+6.1pp
Net margin9%+7.3pp
FCF margin24.5%+2.4pp

Returns & leverage

See full
Return on equity12.8%+10.3pp
Debt / equity0.6×+0.1×
Current ratio0.9×-0.5×

Where this comes from

Reported directly by Q2 Holdings in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice.

The official record: Q2 Holdings’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Q2 Holdings's options forfeited/expired (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Q2 Holdings's options forfeited/expired (in dollars per share)?
Q2 Holdings (QTWO) reported options forfeited/expired (in dollars per share) of $0.00 in Q4 2025.
What does options forfeited/expired (in dollars per share) mean?
The weighted average exercise price of stock options that were forfeited or expired during the period. This metric serves as an indicator of the value threshold at which equity incentives were rendered ineffective for employees.